Blue Bell Private Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$238K Hold
658
– – 0.03% 262
2026
Q1
$231K Buy
658
+1
+0.2% +$356 0.03% 254
2025
Q4
$215K Hold
657
– – 0.03% 248
2025
Q3
$185K Sell
657
-5
-0.8% -$1.45K 0.03% 254
2025
Q2
$185K Buy
662
+436
+193% +$124K 0.03% 243
2025
Q1
$70.5K Buy
226
+57
+34% +$16.8K 0.01% 334
2024
Q4
$44K Buy
169
+1
+0.6% +$297 0.01% 372
2024
Q3
$54.2K Sell
168
-22
-12% -$7.2K 0.01% 349
2024
Q2
$59.4K Hold
190
– – 0.01% 333
2024
Q1
$53.9K Buy
190
+2
+1% +$585 0.01% 343
2023
Q4
$54.2K Sell
188
-69
-27% -$18.8K 0.01% 311
2023
Q3
$69K Sell
257
-24
-9% -$5.99K 0.02% 232
2023
Q2
$62.5K Buy
281
+200
+247% +$46.4K 0.02% 239
2023
Q1
$19.5K Buy
81
+1
+1% +$245 0.01% 322
2022
Q4
$21.1K Sell
80
-100
-56% -$26.8K 0.01% 305
2022
Q3
$41K Buy
180
+50
+38% +$12.1K 0.01% 221
2022
Q2
$32K Buy
130
+105
+420% +$25.7K 0.01% 253
2022
Q1
$6K Hold
25
– – ﹤0.01% 509
2021
Q4
$6K Buy
+25
New +$5.28K ﹤0.01% 485

Other funds holding AMGN

Blue Bell Private Wealth Management's AMGN Position: Q2 2026 in Review

Blue Bell Private Wealth Management held its Amgen (AMGN) position steady in Q2 2026 at 658 shares worth $238K. The position accounts for 0.03% of the portfolio, ranked #262.

Blue Bell Private Wealth Management first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Blue Bell Private Wealth Management held 658 shares of Amgen worth $238K as of Q2 2026.
  • Blue Bell Private Wealth Management left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.03% of Blue Bell Private Wealth Management's portfolio in Q2 2026, its #262 holding.
  • Blue Bell Private Wealth Management first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Blue Bell Private Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.